ASB2 is a direct target of FLI1 that sustains NF-κB pathway activation in germinal center-derived diffuse large B-cell lymphoma.
Sartori G., Napoli S., Cascione L., Chung EYL, Priebe V., Arribas A.J., Mensah A.A., Dall'Angelo M., Falzarano C., Barnabei L. et al., 2021/11/11. Journal of experimental & clinical cancer research, 40 (1) p. 357. Peer-reviewed.
ici le détail
